openPR Logo
Press release

Myasthenia Gravis Treatment Market Trends, Research Report, Growth, Opportunities, Forecast 2022-2028

06-03-2022 12:22 PM CET | Health & Medicine

Press release from: Orion Market Research

The global myasthenia gravis treatment market is anticipated to showcase considerable growth during the forecast period. The rising FDA approvals, advancement in new treatment therapies, new product launches, and improvement in surgical procedures are some of the key factors contributing to the growth of the global myasthenia gravis treatment market. Myasthenia gravis is a chronic autoimmune, neuromuscular disorder that leads to weakness in the skeletal muscles. Eyes, face, and swallowing are the most affected muscles. According to the National Center for Biotechnology Information (NCBI), 0.25 and 20 per 1,000,000 population have an annual incidence of myasthenia gravis.

A full report of Myasthenia Gravis Treatment Market is available at: https://www.omrglobal.com/industry-reports/myasthenia-gravis-treatment-market

LEO Pharma A/S, Mylan N.V., Bausch Health Companies Inc., Bayer HealthCare AG, Encore Dermatology, Inc., Abbvie Inc., Allergan PLC, Bausch Health Companies Inc., Encore Dermatology Inc., GlaxoSmithKline PLC, Nestle SA, Novartis International AG, Pfizer Inc., and so on are among the key players operating in the global myasthenia gravis treatment market. Mergers and acquisitions, partnerships, collaboration, and strategic agreements among others are the key growth strategies that are being adopted by the major players operating in the market to remain competitive in the market place. Hefty investment in the R&D of new drugs for new product launches is the key strategy adopted by the key players of the global myasthenia gravis treatment market to sustain in the marketplace.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/myasthenia-gravis-treatment-market

In November 2019, Amneal Pharmaceuticals, Inc. had signed a licensing agreement with Kashiv BioSciences LLC for the development and commercialization of K127 in the US. K127 is an extended-release tablet of pyridostigmine, for the treatment of myasthenia gravis which is used to offer rapid onset and 24-hour coverage for improved symptom control, better tolerability, better compliance, and quality of life to the myasthenia gravis patients. The commercialization of the product is anticipated to drive the growth of the myasthenia gravis treatment market in the US.
In March 2019, Novartis AG had received FDA approval for Mayzent (siponimod) tablets, the first oral drug to treat the secondary progressive autoimmune disorder. In October 2017, Alexion Pharmaceuticals, Inc. had received the US FDA approval for Soliris (eculizumab) as a treatment for adult patients with generalized myasthenia gravis and are anti-acetylcholine receptor (AchR) antibody-positive. In Phase 3 REGAIN trial and its continuing open-label extension trial, Soliris showed therapeutic advantages for patients with anti-AchR antibody-positive who had previously failed immunosuppressive care and continued to experience severe symptoms of the unresolved disease, which could include problems seeing, walking, communicating, chewing, and respiratory.

Global Myasthenia Gravis Treatment Market Segmentation

By Treatment

• Medication
• Surgery
• Others

By End-User

• Hospitals
• Clinics
• Other

Myasthenia Gravis Treatment Market- Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• AbbVie, Inc.
• Alexion Pharmaceutical, Inc.
• Amneal Pharmaceuticals, Inc.
• Argenx SE
• Astellas Pharma, Inc.
• Avadel Pharmaceuticals PLC
• Bausch Health Companies Inc.
• Baxter International, Inc.
• CSL Behring
• CuraVac, Inc.
• F. Hoffmann-La Roche, Ltd.
• GlaxoSmithKline plc
• Grifols SA
• Immunovant, Inc.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Myasthenia Gravis Treatment Market Trends, Research Report, Growth, Opportunities, Forecast 2022-2028 here

News-ID: 2644323 • Views:

More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sustainability Preferences
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become
Railway Management System Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033. Railway Management System Market Overview The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033. Monocalcium Phosphate Market Overview Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033. Automotive Lubricants Market Overview The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the